Amedisys Statistics
Share Statistics
Amedisys has 32.82M
shares outstanding. The number of shares has increased by 0.41%
in one year.
| Shares Outstanding | 32.82M |
| Shares Change (YoY) | 0.41% |
| Shares Change (QoQ) | 0.17% |
| Owned by Institutions (%) | 91.4% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1,063 |
| FTD / Avg. Volume | 0.29% |
Short Selling Information
The latest short interest is 2.32M, so 7.08% of the outstanding
shares have been sold short.
| Short Interest | 2.32M |
| Short % of Shares Out | 7.08% |
| Short % of Float | 7.2% |
| Short Ratio (days to cover) | 7.51 |
Valuation Ratios
The PE ratio is 68.71 and the forward
PE ratio is 18.53.
Amedisys's PEG ratio is
-0.13.
| PE Ratio | 68.71 |
| Forward PE | 18.53 |
| PS Ratio | 1.26 |
| Forward PS | 1.1 |
| PB Ratio | 2.62 |
| P/FCF Ratio | 13.81 |
| PEG Ratio | -0.13 |
Financial Ratio HistoryEnterprise Valuation
Amedisys has an Enterprise Value (EV) of 3.13B.
| EV / Sales | 1.33 |
| EV / EBITDA | 42.58 |
| EV / EBIT | 14.11 |
| EV / FCF | 14.54 |
Financial Position
The company has a current ratio of 1.23,
with a Debt / Equity ratio of 0.41.
| Current Ratio | 1.23 |
| Quick Ratio | 1.23 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | 6.27 |
| Debt / FCF | 2.14 |
| Interest Coverage | 3.07 |
Financial Efficiency
Return on Equity is 3.81% and Return on Invested Capital is 2.48%.
| Return on Equity | 3.81% |
| Return on Assets | 2.02% |
| Return on Invested Capital | 2.48% |
| Revenue Per Employee | $123,596 |
| Profits Per Employee | $2,275.32 |
| Employee Count | 19,000 |
| Asset Turnover | 1.1 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 48.05M |
| Effective Tax Rate | 55.74% |
Stock Price Statistics
The stock price has increased by 0.71% in the
last 52 weeks. The beta is 0.97, so Amedisys's
price volatility has been higher than the market average.
| Beta | 0.97 |
| 52-Week Price Change | 0.71% |
| 50-Day Moving Average | 92.92 |
| 200-Day Moving Average | 93.56 |
| Relative Strength Index (RSI) | 63.5 |
| Average Volume (20 Days) | 366,188 |
Income Statement
In the last 12 months, Amedisys had revenue of 2.35B
and earned 43.23M
in profits. Earnings per share was 1.32.
| Revenue | 2.35B |
| Gross Profit | 1.02B |
| Operating Income | 94.54M |
| Net Income | 43.23M |
| EBITDA | 73.45M |
| EBIT | 55.45M |
| Earnings Per Share (EPS) | 1.32 |
Full Income StatementBalance Sheet
The company has 303.24M in cash and 460.18M in
debt, giving a net cash position of -156.94M.
| Cash & Cash Equivalents | 303.24M |
| Total Debt | 460.18M |
| Net Cash | -156.94M |
| Retained Earnings | 791.16M |
| Total Assets | 2.18B |
| Working Capital | 141.93M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 221.66M
and capital expenditures -6.55M, giving a free cash flow of 215.12M.
| Operating Cash Flow | 221.66M |
| Capital Expenditures | -6.55M |
| Free Cash Flow | 215.12M |
| FCF Per Share | 6.57 |
Full Cash Flow StatementMargins
Gross margin is 43.34%, with operating and profit margins of 4.03% and 1.84%.
| Gross Margin | 43.34% |
| Operating Margin | 4.03% |
| Pretax Margin | 3.67% |
| Profit Margin | 1.84% |
| EBITDA Margin | 3.13% |
| EBIT Margin | 4.03% |
| FCF Margin | 9.16% |
